BIOVEGEN participates in the Identification of Relevant Scientific and Technological Lines in the Community of Madrid

In the months of June to September 2021, the General Directorate of Research and Technological Innovation of the Community of Madrid has carried out consultations with key actors from the different sectors to identify scientific-technological lines of interest to the Community.

These lines will be an important contribution in the development of the Madrid Research Strategy (EM2i) until 2030, which includes the Smart Specialization Strategy (S3) and the Regional Plan for Scientific Research and Technological Innovation (VI PRICIT). BIOVEGEN, which has been one of the entities consulted, participated on the 7th in the “Health, Food and Active Aging” Table contributing their experience.

The objective of this process is to energize and strengthen the business sector, positioning the Community of Madrid as a leader in the technologies of the future. More than 100 experts have participated in the process, grouped into 7 thematic tables according to the priorities defined in the EM2i.